June 17, 2009
Alert: Hydroxycut Class Action Have Already Been Registered
On May 1, 2009, there was a recall of fourteen Hydroxycut diet-aid products coming from a number of reports that folks using the products were developing significant liver problems and other health worries. Less than seven days later, on May 4, the first Hydroxycut class action suit was filed against the company that manufactures the products, Iovate Medical Sciences. The Hydroxycut Lawyer alleges company neglectfulness in informing the public about potential risks of the products. Naturally, it’s too soon to grasp the suit is going to turn out, but if the company had information which it did not reveal to buyers, it should definitely be held accountable.
A class action court action is filed by a bunch of folks, all of whom have similar claims against a certain company. Filing a class action is just as effective, and much less pricey, than filing an individual suit. As a rule, filing a class action court action will not cost you anything unless there is a settlement. At that point, the lawyer who handled the suit will take his charges from the compensation that got given and then assign the leftover funds to the plaintiffs in the case. Since this is the case, you’ll be ready to file a Hydroxycut class action suit without paying a penny out of your own pocket, which is one of the reasons that class action suits became so popular.
The first class action lawsuit against Iovate was filed in Canada where the company is found and represents all Canadian citizens who sustained health issues due to Hydroxycut products. The FDA recall happened in the US where 23 cases of liver disorders and other health problems had been reported. Health Canada did not receive any reports of liver damage caused by the diet products, but they did receive seventeen reports concerning people who sustained breathing, neurological, cardio, and gut problems as a result of Canadians using the products.
The Hydroxycut Lawsuits alleges that the products without correctly informing the general public of the health hazards that they could exposing buyers to. The complaint states the company failed to publish the information on the product labels stating that users could run the chance of liver and kidney damage as well as gut, cardio, respiratory, and neurological issues. The suit goes on to allege that this was a blatant omission on the part of the company which purposely misled clients concerning the protection of the products.
